80 likes | 95 Views
The global smart insulin pens market was valued at $57 million in 2016, and is projected to reach $117 million by 2023, growing at a CAGR of 10.7% from 2017 to 2023.
E N D
Smart Insulin Pens MarketExpected to reach $117 Million, Globally, by 2023
The Global Smart Insulin Pens Market was valued at $57 million in 2016, and is projected to reach $117 million by 2023, growing at a CAGR of 10.7% from 2017 to 2023. Introduction • The first generation pens segment held more than three-fifths share of the total market in 2016. • Increase in demand for self-injection devices, rise in prevalence of diabetes, and accuracy in dosage delivery of insulin are expected to drive the market growth. • Rise in prevalence of diabetes raises the demand for needle-free insulin delivery devices. • Asia-Pacific offers lucrative opportunities for the market growth, due to its high population base and increase in incidence of diabetic patients.
The first generation pens is projected to grow at the CAGR of 9.7% during the forecast period. • USB connected pens is projected to register the highest growth rate of 12.7% during the forecast period. • Bluetooth-enabled pens segment accounted nearly two-thirds share of the global second generation smart insulin pens market in 2016. • Home care settings is expected to grow at the highest CAGR of 10.9% during the forecast period. • France and Germany collectively contributed for more than one-third share of the European smart insulin pens market in 2016. • Japan was the major shareholder in 2016, accounting for more than one-third share of the Asia-Pacific smart insulin pens market. Key Findings of theMarket
The study provides an in-depth analysis of the global smart insulin pens market, with current trends and future estimations, to elucidate the imminent investment pockets. • Quantitative analysis from 2016 to 2023 of all geographical regions is expected to enable the stakeholders to capitalize on prevailing market opportunities. • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework. Key Benefits Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/3485
MarketSegmentation • By Type • First Generation Pens • Second Generation Pens • Bluetooth-Enabled • USB Connected • By Usability • Prefilled • Reusable • By End User • Hospitals & Clinics • Ambulatory Surgical Centers • Home Care Settings • By Region • North America • Europe • Asia-Pacific • LAMEA
Eli Lilly and Company, • Novo Nordisk, • Companion Medical, • DIAMESCO, and • EmperraGmbH. Key Players of theMarket For purchase enquiry, visit @https://www.alliedmarketresearch.com/purchase-enquiry/3485
About Allied MarketResearch: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective marketdomain. ContactUs: 5933 NE Win Sivers Drive, #205, Portland, OR 97220, UnitedStates. Int'l: +1-503-894-6022 TollFree: +1-800-792-5285 Fax: +1-800-792-5285 Contact Allied MarketResearch
ThankYou! For MoreDetails Visit usat https://www.alliedmarketresearch.com/smart-insulin-pens-market Follow UsOn: